Occupational lead exposure is an independent modulator of hypertension and poor pulmonary function: A cross-sectional comparative study in lead-acid battery recycling workers
Restricted accessResearch articleFirst published online March, 2022
Occupational lead exposure is an independent modulator of hypertension and poor pulmonary function: A cross-sectional comparative study in lead-acid battery recycling workers
Blood lead level (BLL) is the primary biomarker for lead-exposure monitoring in occupationally exposed workers. We evaluated occupational lead-exposure (OE) impact on cardiopulmonary functions in lead-acid battery recycling unit workers. Seventy-six OE cases and 30 control subjects were enrolled for questionnaire-based socio-demographic, dietary, tobacco usage, and medical history data. Anthropometric measurements, systolic and diastolic blood pressure (SBP and DBP), and pulmonary function tests were performed. Venous blood was collected for BLL, hematological analysis, and biochemical analysis. OE caused a significant increase in BLL, SBP, DBP, and small airways obstruction in lung function tests. It also impaired platelet indices, affected renal and liver biochemical measurements, and promoted oxidative stress and DNA damage. Multilinear regression analysis suggested that BLL affected SBP (β = 0.314, p = .034) and increased small airways obstruction (FEV1/FVC, β = −0.37, p = .05; FEV25–75%, β = −0.351, p = .016). Higher BLL appears to be an independent modulator of hypertension and poor pulmonary function upon occupational lead exposure in lead-acid battery recyclers.
Al-NeamyFRMAlmehdiAMAlwashR, et al. (2001) Occupational lead exposure and amino acid profiles and liver function tests in industrial workers. International Journal of Environmental Health Research11(2): 181–188.
2.
ATS (1995) Standardization of spirometry, 1994 update. American thoracic society. American Journal of Respiratory and Critical Care Medicine152(3): 1107–1136.
3.
BarmanTKalahasthiRRajmohanHR (2014) Effects of lead exposure on the status of platelet indices in workers involved in a lead-acid battery manufacturing plant. Journal of Exposure Science & Environmental Epidemiology24(6): 629–633.
4.
BenerAObinecheEGillettM, et al. (2001) Association between blood levels of lead, blood pressure and risk of diabetes and heart disease in workers. International Archives of Occupational and Environmental Health74(5): 375–378.
5.
ChatterjeeABlackSMCatravasJD (2008) Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascular Pharmacology49(4–6): 134–140.
6.
CheungCKYTsangSSLHoO, et al. (2020) Cardiovascular risk in bus drivers. Hong Kong Medical Journal26(5): 451–456.
7.
ChowdhuryRRamondAO’KeeffeLM, et al. (2018) Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis. British Medical Journal362: k3310.
8.
ChungHKChangYSAhnCW (2015) Effects of blood lead levels on airflow limitations in Korean adults: findings from the 5th KNHNES 2011. Environmental Research136: 274–279.
9.
DongreNNSuryakarANPatilAJ, et al. (2013) Biochemical effects of lead exposure on battery manufacture workers with reference to blood pressure, calcium metabolism and bone mineral density. Indian Journal of Clinical Biochemistry28(1): 65–70.
10.
EllmanGL (1959) Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics82(1): 70–77.
11.
FengWHuangXZhangC, et al. (2015) The dose–response association of urinary metals with altered pulmonary function and risks of restrictive and obstructive lung diseases: a population-based study in China. British Medical Journal Open5(5): e007643–e007643.
12.
GonickHBehariJR (2002) Is lead exposure the principal cause of essential hypertension?Medical Hypotheses59(3): 239–246.
13.
HabigWHPabstMJJakobyWB (1974) Glutathione S-transferases the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry249(22): 7130–7139.
14.
Hippisley-CoxJCouplandCBrindleP (2017) Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. British Medical Journal357: j2099.
15.
JanATAzamMSiddiquiK, et al. (2015) Heavy metals and human health: mechanistic insight into toxicity and counter defense system of antioxidants. International Journal of Molecular Sciences16(12): 29592–29630.
16.
KhazdairMRBoskabadyMHAfshariR, et al. (2012) Respiratory symptoms and pulmonary function testes in lead exposed workers. Iranian Red Crescent Medical Journal14(11): 737–742.
17.
KlaassenCD (2006) Heavy metals and heavy-metal antagonict. In: BruntonLLLazoJSParkerKL (eds) Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 11th edition. Newyork, NY: McGraw-Hill, 1754–1758.
18.
Kristal-BonehEFroomPYerushalmiN, et al. (1998) Calcitropic hormones and occupational lead exposure. American Journal of Epidemiology147(5): 458–463.
19.
LiQYounJ-YCaiH (2015) Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension. Journal of Hypertension33(6): 1128–1136.
20.
LustbergMSilbergeldE (2002) Blood lead levels and mortality. Archives of Internal Medicine162(21): 2443–2449.
21.
MadrigalJMPerskyVPappalardoA, et al. (2018) Association of heavy metals with measures of pulmonary function in children and youth: results from the National Health and Nutrition Examination Survey (NHANES). Environment International121: 871–878.
22.
MansouriMTCauliO (2009) Motor alterations induced by chronic lead exposure. Environmental Toxicology and Pharmacology27(3): 307–313.
23.
MasjediM-REstinehNBahadoriM, et al. (1989) Pulmonary complications in lead miners. Chest96(1): 18–21.
24.
MenkeAMuntnerPBatumanV, et al. (2006) Blood lead below 0.48 mmol/L (10 mg/dL) and mortality among US adults. Circulation114(13): 1388–1394.
25.
Miao-LinH (1994) Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol233: 380–383.
26.
MillerMRCrapoRHankinsonJ, et al. (2005) General considerations for lung function testing. European Respiratory Journal26(1): 153–161.
27.
MisraAVikramNKGuptaR, et al. (2006) Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. International Journal of Obesity30(1): 106–111.
28.
MitraPSharmaSPurohitP, et al. (2017) Clinical and molecular aspects of lead toxicity: an update. Critical Reviews in Clinical Laboratory Sciences54(7–8): 506–528.
29.
NashDMagderLLustbergM, et al. (2003) Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA289(12): 1523–1532.
30.
Navas-AcienASelvinESharrettAR, et al. (2004) Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation109(25): 3196–3201.
31.
NawrotTSThijsLDen HondEM, et al. (2002) An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. Journal of Human Hypertension16(2): 123–131.
32.
ParkSBaekKA (2018) Association of general obesity and abdominal obesity with the prevalence of urinary incontinence in women: cross-sectional secondary data analysis. Iranian Journal of Public Health47(6): 830–837.
33.
PietropaoliAPFramptonMWHydeRW, et al. (2004) Pulmonary function, diffusing capacity, and inflammation in healthy and asthmatic subjects exposed to ultrafine particles. Inhalation Toxicology16(Suppl. 1): 59–72.
34.
PirkleJLSchwartzJLandisJR, et al. (1985) The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. American Journal of Epidemiology121(2): 246–258.
35.
Ruiz-HernandezANavas-AcienAPastor-BarriusoR, et al. (2017) Declining exposures to lead and cadmium contribute to explaining the reduction of cardiovascular mortality in the US population, 1988–2004. International Journal of Epidemiology46(6): 1903–1912.
36.
ShahFKaziTGAfridiHI, et al. (2012) Exposures of lead to adolescent workers in battery recycling workshops and surrounding communities. Journal of Exposure Science & Environmental Epidemiology22(6): 649–653.
37.
SinghNPMcCoyMTTiceRR, et al. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research175(1): 184–191.
38.
SnehalathaCViswanathanVRamachandranA (2003) Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care26(5): 1380–1384.
39.
StaessenJARoelsHLauwerysRR, et al. (1995) Low-level lead exposure and blood pressure. Journal of Human Hypertension9(5): 303–328.
40.
TanMHJohnsDGlazerNB (2004) Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clinical Chemistry50(7): 1184–1188.
41.
UpadhyayKViramgamiAPagdhuneA, et al. (2021) Hematological and cardiovascular effects of chronic low level lead exposure: a study on e-waste recyclers. Clinical Epidemiology and Global Health9: 269–274.
42.
VaziriND (2008) Mechanisms of lead-induced hypertension and cardiovascular disease. American Journal of Physiology-Heart and Circulatory Physiology295(2): H454–H465.
43.
WaniALUsmaniJA (2016) Occupational stress among workers having exposure to lead. Clinical Epidemiology and Global Health4(4): 163–170.
44.
WillsED (1966) Mechanisms of lipid peroxide formation in animal tissues. Biochemical Journal99(3): 667–676.
45.
WuT-NShenC-YKoK-N, et al. (1996) Occupational lead exposure and blood pressure. International Journal of Epidemiology25(4): 791–796.
46.
XieJYuJFanY, et al. (2020) Low dose lead exposure at the onset of puberty disrupts spermatogenesis-related gene expression and causes abnormal spermatogenesis in mouse. Toxicology and Applied Pharmacology393: 114942
47.
YuCCLinJLLin-TanDT (2004) Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. Journal of the American Society of Nephrology15(4): 1016–1022.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
